Dr. Oliver Soehnlein is DZHK Professor for Vascular Immunotherapy at the Institute for Cardiovascular Prevention at the LMU in Munich. His research focuses on the role of myeloid cells in vascular inflammation. On the basis of refined pathophysiological understanding, he aims to design tailored therapeutic approaches.